OncoMethylome
Europe, Liege, Belgium, Liège
Description
OncoMethylome is a molecular diagnostics company developing gene methylation tests for early detection of cancer.
Investor Profile
OncoMethylome has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 1 rounds, about 50% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series C, Series B rounds (top funding stages).
- Majority of deals are located in Germany.
- Strong thematic focus on Biotechnology, Health Care, Oncology.
Stage Focus
- Series C (50%)
- Series B (50%)
Country Focus
- Germany (100%)
Industry Focus
- Biotechnology
- Health Care
- Oncology
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
